Trade ELTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Elicio Therapeutics, Inc. (ELTX) is trading at US$1.79, up 1.13% today as of Oct 14, 16:00 EDT. The company has a market capitalisation of US$79.9M. Over the past 52 weeks, ELTX has traded between US$1.71 and US$16.00. On Syfe you can trade ELTX with $0 commission and add it to your watchlist.
| Previous close | US$1.77 |
|---|---|
| Market cap | US$79.9M |
| 52-week range | US$1.71 – US$16.00 |
| Volume | 373.25K |
| Exchange | US |
Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
Year: 2023
Elicio Therapeutics Closes $15 Million Registered Direct Offering
Jul 6, 9:39 PM · MT Newswires
Top Midday Decliners
Jul 2, 5:58 PM · MT Newswires
Top Premarket Decliners
Jul 2, 11:32 AM · MT Newswires
Elicio Therapeutics Prices $15 Million Direct Offering
Jul 2, 7:39 AM · MT Newswires
Elicio Therapeutics, Inc. (ELTX) stock is trading at US$1.79, +1.13% from the previous close of US$1.77.
The market cap for Elicio Therapeutics, Inc. (ELTX) stock is approximately US$79.9M.
The 52-week high for Elicio Therapeutics, Inc. (ELTX) stock is US$16.00.
The 52-week low for Elicio Therapeutics, Inc. (ELTX) stock is US$1.71.
Elicio Therapeutics, Inc. (ELTX) does not currently pay a dividend.
Stay on top of ELTX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
